Frontlight ResearchEarly access
Cystic fibrosis trials in Czechia
4 of 5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in CzechiaSafety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis
- Where
- Prague
- Age
- 18 years and over
- People
- 64 worldwide
- Run by
- SpliSense Ltd.
See details and how to joinNCT06429176 - Phase 2Taking peopleSafety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients with Cystic Fibrosis
- Where
- Praha 5 - Motol
- Age
- 18 years and over
- People
- 30 worldwide
- Run by
- Splisense Ltd.
See details and how to join2024-511184-28-00 - Phase 2Not yet taking people in CzechiaSafety and Efficacy of VX-828/Deutivacaftor Combination Therapy With and Without Tezacaftor in Subjects With Cystic Fibrosis
- Where
- Brno, Prague
- Age
- 18 years and over
- People
- 80 worldwide
- Run by
- Vertex Pharmaceuticals Inc.
See details and how to join2025-523400-72-00 - Phase 3Taking peopleThe randomized, double blind study phase III.b of the Comprehensive assessment of the musculoskeletal health in children with cystic fibrosis – on the search for means of improvement
- Where
- Prague
- Age
- Up to 17 years
- People
- 64
- Run by
- Fakultni Nemocnice V Motole
See details and how to join2024-517886-18-00